Longevity Base

The Longevity Base is an advanced peptide protocol targeting two fundamental pillars of biological aging: telomere maintenance and systemic tissue repair. By pairing Epithalon, a synthetic tetrapeptide that activates telomerase, with BPC-157, a gastric pentadecapeptide with extraordinary regenerative properties, this stack addresses aging at both the chromosomal and cellular-functional levels. Epithalon at 10mg administered subcutaneously daily for a 10-day cycle directly stimulates telomerase production in somatic cells. Telomerase is the enzyme responsible for maintaining telomere length, the protective caps on chromosomes that shorten with each cell division and serve as a primary biological clock of aging. Research by Professor Vladimir Khavinson, who pioneered Epithalon development, demonstrated measurable telomere elongation, improved neuroendocrine function, and extended lifespan in animal models. The 10-day intensive protocol followed by extended rest periods (typically 4-6 months between cycles) mirrors the pulsatile approach used in clinical research settings. BPC-157 at 250mcg daily provides continuous systemic repair signaling throughout and beyond the Epithalon cycle. This peptide upregulates growth factor expression (VEGF, EGF, and others), promotes angiogenesis, accelerates wound healing, protects and heals gut lining, and demonstrates neuroprotective properties. Its role in this stack is to maintain tissue integrity and repair capacity while Epithalon works at the deeper chromosomal level. Administer Epithalon subcutaneously in the morning during the 10-day intensive phase. BPC-157 can be taken at any consistent time daily and is continued beyond the Epithalon cycle as a maintenance peptide. This stack is designed for advanced users with established health optimization practices who are focused on long-term biological age reduction. It is particularly suited for those over 40 seeking to slow or partially reverse cellular aging markers. The combination is supported by decades of Russian gerontological research on Epithalon and a growing body of literature on BPC-157 systemic repair mechanisms. Users should monitor biomarkers including telomere length testing, inflammatory markers, and hormonal panels to track progress across cycles.